Brooklyn Investment Group’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$218K Buy
+10,282
New +$206K 0.01% 1656
2025
Q3
Sell
-3,352
Closed -$38.8K 2547
2025
Q2
$38.8K Buy
3,352
+2,558
+322% +$23.3K 0.01% 1479
2025
Q1
$6.93K Buy
794
+793
+79,300% +$10K ﹤0.01% 1684
2024
Q4
$15 Sell
1
-256
-100% -$4.04K ﹤0.01% 1902
2024
Q3
$5.8K Buy
+257
New +$5.31K ﹤0.01% 851

Other funds holding TXG

Brooklyn Investment Group's TXG Position: Q1 2026 in Review

Brooklyn Investment Group opened a new position in 10x Genomics (TXG) in Q1 2026: 10,282 shares worth $218K. The stake represents 0.01% of the portfolio and ranks #1656 among its holdings. This is a return to the name: Brooklyn Investment Group previously reported a position in TXG as recently as Q2 2025.

Brooklyn Investment Group first reported a position in TXG in Q3 2024 and has held it in 5 quarters since. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Brooklyn Investment Group held 10,282 shares of 10x Genomics worth $218K as of Q1 2026.
  • 10x Genomics was a new Brooklyn Investment Group position in Q1 2026.
  • 10x Genomics made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1656 holding.
  • Brooklyn Investment Group first reported a position in 10x Genomics in Q3 2024 and has held it in 5 quarters since.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.